News | October 31, 2014

American College of Cardiology Patient Navigator Program Completes Hospital Selection

Program seeks to lower readmission rates for heart attack and heart failure patients

October 31, 2014 — The American College of Cardiology announced 35 selected hospitals that are pioneering a team approach to keep patients healthy and at home following admission for heart attack or heart failure. The hospitals from across the country are the first participants in the ACC Patient Navigator Program, which is the first program of its kind in cardiology and supports national efforts to reduce unnecessary patient readmissions.

“The Patient Navigator Program is a unique collaboration between the cardiovascular care team, patients and families to manage the stress of hospitalization for complex conditions in a way that allows patients to return home, remain healthy and avoid the need for readmission whenever possible,” said ACC President Patrick T. O’Gara, M.D., FACC. “The program coincides with national initiatives to reduce readmission rates for patients with cardiovascular conditions. More importantly, it will directly benefit patients and their families.”

Nearly one in five Medicare patients hospitalized with heart attack and one in four Medicare patients hospitalized with heart failure are readmitted within 30 days of discharge, often for conditions seemingly unrelated to their original diagnosis. Readmissions can be related to issues ranging from the stresses of the initial hospitalization, to patient fragility at time of discharge, a lack of understanding of discharge instructions, and the inability to carry out discharge instructions.

As of Oct. 1, the Centers for Medicare and Medicaid Services increased penalties for hospitals with excessive 30-day readmission rates for heart attack, heart failure and three other non-cardiac conditions to a maximum of 3 percent of related CMS reimbursements. Penalties were implemented beginning in 2012 and maximum penalties have increased annually by 1 percentage point.

After an initial implementation and assessment period, hospitals in the Patient Navigator Program will implement a variety of evidence-based processes to help their patients avoid readmissions. Processes can include scheduling seven-day follow up appointments and discussing and providing the patient with documentation of their treatment regimen, all prescribed medications and community resources. Established programs will serve as models that can be implemented in other hospitals as the initiative grows. AstraZeneca is the founding sponsor of the ACC Patient Navigator Program.

Below is a list of the 35 participating hospitals, chosen because of their commitment to quality as demonstrated by participation in the National Cardiovascular Data Registry and Hospital to Home programs:  

1.  Advocate Sherman Hospital, Elgin, Ill.

2.  Aurora BayCare Medical Center, Green Bay, Wis.

3.  Baptist Health Louisville, Louisville, Ky.

4.  Barnes-Jewish Hospital at Washington University Medical Center, St. Louis, Mo.

5.  California Pacific Medical Center, San Francisco

6.  Christiana Care Health Services, Wilmington, Del.

7.  Einstein Medical Center, Philadelphia

8.  Fairview Hospital, a Cleveland Clinic Hospital, Cleveland

9.  Huntsville Hospital, Huntsville, Ala.

10. Indian River Medical Center, Vero Beach, Fla.

11. Indiana University Health Methodist Hospital, Indianapolis

12. Lynchburg General Hospital Centra Health, Lynchburg, Va.

13. MedStar Washington Hospital Center, Washington

14. Mercy Hospital, Portland, Maine

15. Mercy Medical Center – Des Moines, Des Moines, Iowa

16. Montefiore Medical Center, New York

17. Newark Beth Israel Medical Center, Newark, N.J.

18. Olathe Medical Center, Olathe, Kan.

19. Providence St. Vincent Medical Center, Portland, Ore.

20. Renown Institute for Heart & Vascular Health, Reno, Nev.

21. Ronald Reagan UCLA Medical Center, Los Angeles

22. St. Mary’s Hospital, Waterbury, Conn.

23. St. Vincent’s Medical Center, Bridgeport, Conn.

24. Scott & White Healthcare, Temple, Texas

25. Tacoma General Hospital Multicare Health System, Tacoma, Wash.

26. Trident Health, Charleston, S.C.

27. University of Colorado Hospital, Aurora, Colo.

28. UT Southwestern Medical Center, Dallas

29. University of Utah Health Care, Salt Lake City, Utah

30. Vanderbilt Heart and Vascular Institute, Nashville, Tenn.

31. VCU Pauley Heart Center, Richmond, Va.

32. WakeMed Health and Hospital, Raleigh, N.C.

33. West Jefferson Medical Center, Marrero, La.

34. Western Maryland Health System, Cumberland, Md.

35. Wyoming Medical Center, Casper, Wyo.

For more information:

Related Content

Gencaro Does Not Reduce Atrial Fibrillation Risk in Heart Failure Patients
News | Heart Failure | May 30, 2018
Data from the GENETIC-AF trial was presented in a “Late Breaking Clinical Trials” oral presentation at the European...
Cardiac Contractility Modulation Safe and Effective as Heart Failure Treatment

Image courtesy of Impulse Dynamics

News | Heart Failure | May 18, 2018
In a new study, cardiac contractility modulation (CCM) therapy was confirmed to significantly improve exercise...
V-Wave Closes $70M Financing to Support Pivotal Study of Heart Failure Therapy
News | Heart Failure | May 16, 2018
Israel-based V-Wave Ltd. recently closed a $70 million Series C financing for its proprietary, minimally invasive...
News | Heart Failure | May 14, 2018
Ancora Heart Inc. announced the expansion of the company’s U.S. feasibility study to evaluate the investigational...
Protein Clumping May Contribute to Heart Failure Development

A PET scan detects clumping proteins in rat hearts (top). The enlarged heart (right) is one with heart failure. Other PET scans showing blood flow in the rat hearts (bottom) show that the protein clumps aren't due to circulation problems. Image courtesy of Circulation Research, May 11, 2018.

News | Heart Failure | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
Minnesota Living With Heart Failure Questionnaire Qualified for FDA Medical Device Development Tools Program

The CORolla device from Israel-based CorAssist is one example of new devices being manufactured and tested to treat heart failure. The efficacy of this and other new devices under development can now be assessed with the Minnesota Living With Heart Failure Questionnaire. 

Technology | Heart Failure | May 07, 2018
The U.S. Food and Drug Administration (FDA) has qualified the Minnesota Living with Heart Failure Questionnaire from...
Nation's First Heart Failure and Arrhythmia Center Opening in Ohio

Image courtesy of The Ohio State University

News | Heart Failure | April 04, 2018
The Ohio State University Wexner Medical Center will establish the nation’s first center dedicated to treating those...
Abbott Initiates GUIDE-HF Trial for Improved Outcomes With CardioMEMS Monitor
News | Heart Failure | March 29, 2018
Abbott announced the company has initiated the landmark GUIDE-HF clinical trial using the CardioMEMS HF System. The...
Videos | Heart Failure | March 23, 2018
David Lanfear M.D., FACC, head of advanced heart failure and cardiac transplantation, Henry Ford Hospital, Detroit, d
Guideline Adherence, Not Patient Volume, May Be Better Hospital Heart Failure Metric
News | Heart Failure | February 01, 2018
February 1, 2018 –  In evaluating the quality of care given to those hospitalized with...
Overlay Init